Nouvelle déclaration d'incident
No de la demande: 2012-5428
Numéro de référence du titulaire d'homologation: 4887086
Nom du titulaire (nom légal complet, aucune abbréviation): Sure-Gro Inc.
Adresse: 150 Savannah Oaks Dr.
Ville: Brantford
État: Ontario
Pays: Canada
Code postal /Zip: N3V 1E7
Incident chez un animal domestique
Pays: CANADA
État: NEW BRUNSWICK
ARLA No d'homologation 26191 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: CIL Ant Roach and Crawling Insect Killer 2
Oui
Inconnu
Propriétaire de l'animal
Dog / Chien
Smooth Collie
1
Femme
1
13
lbs
Orale
Unknown / Inconnu
>8 hrs <=24 hrs / > 8 h < = 24 h
Système
Unknown / Inconnu
Non
Inconnu
Unknown/Inconnu
Other / Autre
préciser possible ingestion of poisoned bugs
(p.ex. description des symptômes tels que la fréquence et la gravité
Owner stated the product was sprayed yesterday evening around 20:00CST. The dog may have eaten some of the bugs that were killed from the product. Owner did sweep up a majority of the dead insects. This morning around 10:00 CST owner noticed that the dog has been lethargic today, has not been eating well and is not drinking much either. The dog is normally very active, and an enthusiastic eater/drinker. These behaviors are very abnormal for her. Owner also stated that the dog's gums are pale. The caller was advised that we can see some signs of nausea and stomach upset if the dog were to ingest some of the product we would also likely see some neurological signs as well. Owner should have the dog evaluated by DVM to determine any other potential causes of the signs the dog has been displaying. DVM can call with questions if needed.
Mineure
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified.